These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11739705)
41. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. Wool-Lewis RJ; Bates P J Virol; 1998 Apr; 72(4):3155-60. PubMed ID: 9525641 [TBL] [Abstract][Full Text] [Related]
42. Cathepsin B & L are not required for ebola virus replication. Marzi A; Reinheckel T; Feldmann H PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527 [TBL] [Abstract][Full Text] [Related]
43. Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak. Dietzel E; Schudt G; Krähling V; Matrosovich M; Becker S J Virol; 2017 Jan; 91(2):. PubMed ID: 27847361 [TBL] [Abstract][Full Text] [Related]
44. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. Martinez O; Ndungo E; Tantral L; Miller EH; Leung LW; Chandran K; Basler CF J Virol; 2013 Mar; 87(6):3324-34. PubMed ID: 23302883 [TBL] [Abstract][Full Text] [Related]
45. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein. Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723 [TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of ebola virus GP1 in viral entry. Manicassamy B; Wang J; Jiang H; Rong L J Virol; 2005 Apr; 79(8):4793-805. PubMed ID: 15795265 [TBL] [Abstract][Full Text] [Related]
47. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. Sanchez A; Yang ZY; Xu L; Nabel GJ; Crews T; Peters CJ J Virol; 1998 Aug; 72(8):6442-7. PubMed ID: 9658086 [TBL] [Abstract][Full Text] [Related]
48. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Côté M; Misasi J; Ren T; Bruchez A; Lee K; Filone CM; Hensley L; Li Q; Ory D; Chandran K; Cunningham J Nature; 2011 Aug; 477(7364):344-8. PubMed ID: 21866101 [TBL] [Abstract][Full Text] [Related]
49. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity. Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855 [TBL] [Abstract][Full Text] [Related]
50. Recombinant Lloviu virus as a tool to study viral replication and host responses. Hume AJ; Heiden B; Olejnik J; Suder EL; Ross S; Scoon WA; Bullitt E; Ericsson M; White MR; Turcinovic J; Thao TTN; Hekman RM; Kaserman JE; Huang J; Alysandratos KD; Toth GE; Jakab F; Kotton DN; Wilson AA; Emili A; Thiel V; Connor JH; Kemenesi G; Cifuentes D; Mühlberger E PLoS Pathog; 2022 Feb; 18(2):e1010268. PubMed ID: 35120176 [TBL] [Abstract][Full Text] [Related]
51. Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein. Liu JL; Shriver-Lake LC; Anderson GP; Zabetakis D; Goldman ER Microb Cell Fact; 2017 Dec; 16(1):223. PubMed ID: 29233140 [TBL] [Abstract][Full Text] [Related]
52. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism. González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839 [TBL] [Abstract][Full Text] [Related]
53. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Mpanju OM; Towner JS; Dover JE; Nichol ST; Wilson CA Virus Res; 2006 Nov; 121(2):205-14. PubMed ID: 16839637 [TBL] [Abstract][Full Text] [Related]
54. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus. Barrientos LG; O'Keefe BR; Bray M; Sanchez A; Gronenborn AM; Boyd MR Antiviral Res; 2003 Mar; 58(1):47-56. PubMed ID: 12719006 [TBL] [Abstract][Full Text] [Related]
55. Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity. Lee J; Nyenhuis DA; Nelson EA; Cafiso DS; White JM; Tamm LK Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E7987-E7996. PubMed ID: 28874543 [TBL] [Abstract][Full Text] [Related]
56. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger. Markosyan RM; Miao C; Zheng YM; Melikyan GB; Liu SL; Cohen FS PLoS Pathog; 2016 Jan; 12(1):e1005373. PubMed ID: 26730950 [TBL] [Abstract][Full Text] [Related]
57. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines. Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111 [TBL] [Abstract][Full Text] [Related]
58. The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development. Zhu W; Banadyga L; Emeterio K; Wong G; Qiu X Viruses; 2019 Oct; 11(11):. PubMed ID: 31683550 [TBL] [Abstract][Full Text] [Related]
59. Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus. Zai J; Yi K; Xie L; Zhu J; Feng X; Li Y Diagn Pathol; 2018 Dec; 13(1):96. PubMed ID: 30567559 [TBL] [Abstract][Full Text] [Related]
60. Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca2+, and receptor binding. Das DK; Bulow U; Diehl WE; Durham ND; Senjobe F; Chandran K; Luban J; Munro JB PLoS Biol; 2020 Feb; 18(2):e3000626. PubMed ID: 32040508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]